Clinical characteristics, treatment, and wound management of pyoderma gangrenosum: A case series. [PDF]
Wang F +6 more
europepmc +1 more source
Corticosteroids in non-viral acute respiratory distress syndrome (ARDS): recommendations outpace evidence - a concise review. [PDF]
Nguyen TL, Pham PT, Duong VP, Duong HNT.
europepmc +1 more source
Characteristics of adverse drug reactions and risk management strategies for methylprednisolone sodium succinate in the treatment of idiopathic sudden sensorineural hearing loss: a clinical study of 1026 patients. [PDF]
Wu T +5 more
europepmc +1 more source
Corticosteroid-induced manic and/or psychotic symptoms: a systematic review. [PDF]
Gostoli S +5 more
europepmc +1 more source
Idiopathic Granulomatous Mastitis: Immune-Pathogen Imbalance in a Treatment-Resistant Benign Inflammatory Disease. [PDF]
Wang S, Liu R, Yan S, Zhao P.
europepmc +1 more source
Successful management of paraquat poisoning: a case report. [PDF]
Havaldar AA.
europepmc +1 more source
Granzyme B as a potential biological target in toxic encephalopathy: A big data-based exploratory analysis. [PDF]
Liu L, Wang J, Liu C.
europepmc +1 more source
Related searches:
The absolute bioavailability and pharmacokinetic parameters of two methylprednisolone formulations (methylprednisolone sodium succinate and methylprednisolone acetate) were determined in five dogs. Plasma concentrations of methylprednisolone, methylprednisolone sodium succinate, and methylprednisolone acetate were measured by sensitive and specific ...
P.M. Fayolle +3 more
openaire +3 more sources
Summary Enzymatic hydrolysis of methylprednisolone hemisuccinate with a non-specific carboxylesterase from hog liver was examined. The carboxyl-exterase was found to be useful in hydrolyzing methylprednisolone hemisuccinate to methylprednisolone.
T. Oshima, E. Nakajima, K. Hattori
openaire +3 more sources
Pharmacokinetics of Methylprednisolone Hemisuccinate and Methylprednisolone in Chronic Liver Disease
The Journal of Clinical Pharmacology, 1993The disposition of methylprednisolone (MP) and its prodrug hemisuccinate (MPHS) was assessed in six middle‐aged patients with chronic liver disease (CLD) and compared with six younger, healthy subjects after a single IV dose of 25.4 mg of MPHS. Blood and urine samples were collected over 12 hours.
Elizabeth A. Ludwig +3 more
openaire +3 more sources

